Opko Health Competitors and Similar CompaniesClear all
Opko Health's competitors and similar companies include Medicalsystem Biotechnology, Interpace Diagnostics, Sysmex Inostics and Prometheus Biosciences.
 Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. |  Medicalsystem Biotechnology Medicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider. |  Interpace Diagnostics Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies. |  Sysmex Inostics Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers. |  Prometheus Biosciences Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases. | |
Founding Date | Founding Date 2007 | Founding Date 2003 | Founding Date 1987 | Founding Date 2008 | Founding Date 1995 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Miami, US HQ Woburn, US | Locations Ningbo Shi, CN HQ | Locations Parsippany-Troy Hills, US HQ Morrisville, US Pittsburgh, US | Locations Hamburg, DE HQ Kobe, JP Baltimore, US | Locations San Diego, US HQ |
Employees | Employees 6,0967% increase | Employees 2,104 | Employees 8919% increase | Employees 65 | Employees 9735% increase |
Valuation ($) | Valuation ($) 1.1 b | Valuation ($) 578.8 m | Valuation ($) 11.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $606.9m (FY, 2025) | Revenue (est.) ¥1.7b (FY, 2024) | Revenue (est.) $38.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $6.8m (FY, 2022) |
Cost of goods | Cost of goods $400.9m (FY, 2025) | Cost of goods ¥966.1m (FY, 2024) | Cost of goods $14.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $205.9m (FY, 2025) | Gross profit ¥761m (FY, 2024) | Gross profit $24.1m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($225.7m) (FY, 2025) | Net income ¥262.7m (FY, 2024) | Net income $24.6m (FY, 2025) | Net income N/A | Net income ($141.8m) (FY, 2022) |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) 1 (FY, 2016) | Patents (US) N/A | Patents (US) 11 (Mar, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 31m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 130m |
For sources of this data, please see the company profile
View Company Profiles
Medicalsystem Biotechnology
HQ
Ningbo Shi, CN
Employees
2,104
Medicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider.
View companyInterpace Diagnostics
HQ
Parsippany-Troy Hills, US
Employees
89↑ 19% increase
Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.
View companySysmex Inostics
HQ
Hamburg, DE
Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and researchers.
View companyPrometheus Biosciences
HQ
San Diego, US
Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases.
View company